SEC Approval Clears Way for Acacia and CombiMatrix to Split Aug. 15 | GenomeWeb
NEW YORK (GenomeWeb News) — The Securities and Exchange Commission has declared that Acacia Research and CombiMatrix can split apart on Aug. 15 after completing a share trade.
 
At that date, every 10 shares of Acacia Research-CombiMatrix common stock will be redeemed for one share of CombiMatrix Corporation common stock.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.